S&P 500

5.970,84

-1,11%

Negocie como um profissional: Aproveite discussões em tempo real e ideias que movimentam o mercado para superar a concorrência.

Cadastre-se

Início
Investir
Ações
Canadá
TSX
Oncolytics Biotech Inc (ONC)
Oncolytics Biotech Inc (ONC) Notícias

ONC

Oncolytics Biotech (ONC)

Oncolytics Biotech Inc

De:

Notícias regulamentadas

Procure um Texto:

Ordenação:

Notícias não regulamentadas

Apresentando as notícias mais relevantes sobre:TSX:ONC

1 2 3 4 5 6 7 8 9 10 Próxima >>

Data	Hora	Fonte	Título	Código	Companhia
26/09/2023	09:00	PR Newswire (US)	THE PANCREATIC CANCER ACTION NETWORK SELECTS ONCOLYTICS BIOTECH® INC. TO RECEIVE $5 MILLION THERAPEUTIC ACCELERATOR AWARD TO DEVELOP LEADING-EDGE TREATMENTS	TSX:ONC	Oncolytics Biotech Inc
01/06/2022	13:23	PR Newswire (Canada)	Suspension de la négociation par l'OCRCVM - ONC.WT	TSX:ONC	Oncolytics Biotech Inc
01/06/2022	13:21	PR Newswire (Canada)	IIROC Trading Halt - ONC.WT	TSX:ONC	Oncolytics Biotech Inc
10/01/2022	13:57	PR Newswire (US)	New Developments in Fight Against Blood Cancers, in Leadup to US$17.1 Billion Market by 2024	TSX:ONC	Oncolytics Biotech Inc
09/04/2021	12:56	PR Newswire (Canada)	L'OCRCVM permet la reprise de la négociation - ONC	TSX:ONC	Oncolytics Biotech Inc
09/04/2021	12:56	PR Newswire (Canada)	IIROC Trade Resumption - ONC	TSX:ONC	Oncolytics Biotech Inc
09/04/2021	12:53	PR Newswire (Canada)	Suspension de la négociation par l'OCRCVM - ONC	TSX:ONC	Oncolytics Biotech Inc
09/04/2021	12:52	PR Newswire (Canada)	IIROC Trading Halt - ONC	TSX:ONC	Oncolytics Biotech Inc
27/12/2017	10:00	PR Newswire (US)	Oncolytics Biotech® Announces Poster Presentation at the 2018 Gastrointestinal Cancers Symposium Sponsored by ASCO in Patien...	TSX:ONC	Oncolytics Biotech Inc
05/12/2017	10:00	PR Newswire (US)	Oncolytics Biotech® Receives Favorable Final Advice Letter from the European Medicines Agency for REOLYSIN® in Metastatic B...	TSX:ONC	Oncolytics Biotech Inc
04/12/2017	10:00	PR Newswire (US)	Oncolytics Biotech® to Present at the Oncolytic Virotherapy Summit	TSX:ONC	Oncolytics Biotech Inc
30/11/2017	10:00	PR Newswire (US)	Oncolytics Biotech® Establishes Scientific Advisory Board Focused on REOLYSIN® Registration Study in Metastatic Breast Canc...	TSX:ONC	Oncolytics Biotech Inc
16/11/2017	20:00	PR Newswire (Canada)	Oncolytics Biotech® Inc. and Adlai Nortye Enter into USD $86.6 Million Regional Licensing Agreement for REOLYSIN®	TSX:ONC	Oncolytics Biotech Inc
08/11/2017	10:00	PR Newswire (US)	Oncolytics Biotech® Inc. Announces 2017 Third Quarter Results	TSX:ONC	Oncolytics Biotech Inc
02/11/2017	09:00	PR Newswire (US)	Oncolytics Biotech® Appoints Deborah Brown to Board of Directors	TSX:ONC	Oncolytics Biotech Inc
11/10/2017	08:00	PR Newswire (US)	Oncolytics Biotech® to Present at the 2017 BIO Investor Forum	TSX:ONC	Oncolytics Biotech Inc
19/09/2017	08:00	PR Newswire (US)	Oncolytics Biotech® to Present at the Phacilitate Immuno-Oncology Frontiers Conference	TSX:ONC	Oncolytics Biotech Inc
18/09/2017	08:00	PR Newswire (US)	Oncolytics Biotech® Announces Successful End-of-Phase 2 Meeting with FDA for REOLYSIN® in Metastatic Breast Cancer	TSX:ONC	Oncolytics Biotech Inc
14/09/2017	08:00	PR Newswire (US)	Oncolytics Biotech® Announces First Patient Treated in MUK eleven Study	TSX:ONC	Oncolytics Biotech Inc
11/09/2017	08:00	PR Newswire (US)	Oncolytics Biotech® Announces the Presentation of REOLYSIN® Clinical Data at ESMO 2017 Congress	TSX:ONC	Oncolytics Biotech Inc
03/08/2017	08:00	PR Newswire (US)	Oncolytics Biotech® Inc. Announces 2017 Second Quarter Results	TSX:ONC	Oncolytics Biotech Inc
01/08/2017	08:00	PR Newswire (US)	Oncolytics Biotech® Inc. to Present at the Canaccord Genuity 37th Annual Growth Conference	TSX:ONC	Oncolytics Biotech Inc
26/07/2017	08:00	PR Newswire (US)	Oncolytics Biotech® to Present REOLYSIN® Safety Data in combination with chemotherapy at ESMO 2017 Congress	TSX:ONC	Oncolytics Biotech Inc
29/06/2017	08:00	PR Newswire (Canada)	Oncolytics® Biotech Inc. Appoints Andrew de Guttadauro, President of Oncolytics Biotech (U.S.) Inc.	TSX:ONC	Oncolytics Biotech Inc
27/06/2017	08:00	PR Newswire (US)	Oncolytics Biotech® Inc. Opens U.S. Based Office in San Diego	TSX:ONC	Oncolytics Biotech Inc
01/06/2017	10:44	PR Newswire (Canada)	L'OCRCVM permet la reprise de la négociation - ONC.WT	TSX:ONC	Oncolytics Biotech Inc
01/06/2017	10:43	PR Newswire (Canada)	IIROC Trade Resumption - ONC.WT	TSX:ONC	Oncolytics Biotech Inc
01/06/2017	10:27	PR Newswire (US)	Oncolytics Biotech® Announces Closing of Public Offering of Units	TSX:ONC	Oncolytics Biotech Inc
24/05/2017	11:39	PR Newswire (US)	Oncolytics Biotech® Prices Public Offering of Units	TSX:ONC	Oncolytics Biotech Inc
23/05/2017	20:09	PR Newswire (US)	Oncolytics Biotech® Announces Proposed Public Offering	TSX:ONC	Oncolytics Biotech Inc